AllAnalyst Report
logoMorningstarOctober 27, 2020

Pfizer Inc.: Pfizer Faces Modest Pressures in Q3, but COVID-19 Vaccine Is Poised to Report Key Data Shortly

Symbols
PFE
Sector(s)
Healthcare
Rating
Premium
Current Price
$40.34
Fair Value
Premium
Economic Moat
Premium
Stewardship
Premium
Summary

Pfizer is one of the world's largest pharmaceutical firms, with annual sales over $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, neuroscience drug Lyrica, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor, representing over a fifth of total firm sales.

Premium
Subscribe to Yahoo Finance Premium for full access
Read the latest independent research including analyst forecasts, ratings on the US economy, and more. Get individual company and overall sector level recommendations.
Try Premium FREE